United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine 20 mg - paroxetine tablets, usp are indicated for the treatment of major depressive disorder.  the efficacy of paroxetine in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine in hospitalized depressed patients have not been adequately studied.  the efficacy of paroxetine in ma

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine tablets, usp are indicated for the treatment of major depressive disorder.  the efficacy of paroxetine in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation.  the effects of paroxetine in hospitalized depressed patients have not been adequately studied.  the efficacy of paroxetine in m

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - sulindac (unii: 184sns8vuh) (sulindac - unii:184sns8vuh) - carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). sulindac is indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. osteoarthritis 2. rheumatoid arthritis** 3. ankylosing spondylitis 4. acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis) 5. acute gouty arthritis **the safety and effectiveness of sulindac tablets usp have not been established in rheumatoid arthritis patients who are designated in the american rheumatism association classification as functional class iv (incapacitated, largely or wholly bedridden, or confined to wheelchair, little or no self-care). sulindac is contraindicated in patients with known hypersensitivity to sulindac or the excipients (see description ). sulindac should not be given to patients

United States - English - NLM (National Library of Medicine)

strategic sourcing services llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness 

United States - English - NLM (National Library of Medicine)

strategic sourcing services, llc (health mart) - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness 

United States - English - NLM (National Library of Medicine)

dolgencorp, llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

United States - English - NLM (National Library of Medicine)

winco foods, llc - dimenhydrinate (unii: jb937per5c) (diphenhydramine - unii:8gts82s83m, 8-chlorotheophylline - unii:ge2ua340fm) - dimenhydrinate 50 mg - antiemetic  for prevention and treatment of these symptoms associated with motion sickness: - nausea - vomiting - dizziness

United States - English - NLM (National Library of Medicine)

healthy accents (dza brands, llc) - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride 25 mg - antiemetic for prevention and treatment of these symptoms associated with motion sickness: - nausea - vomiting - dizziness

United States - English - NLM (National Library of Medicine)

top care (topco associates llc) - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride 25 mg - antiemetic for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness.

United States - English - NLM (National Library of Medicine)

chain drug consortium, llc - dimenhydrinate (unii: jb937per5c) (diphenhydramine - unii:8gts82s83m) - dimenhydrinate 50 mg - antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness.